Risk Factors of Incisional Hernias After Emergency Midline Laparotomy
Launched by HERLEV HOSPITAL · Aug 18, 2022
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding what factors may lead to the development of incisional hernias after patients undergo emergency midline laparotomy surgery. An incisional hernia is a bulge that can occur at the site of a surgical incision, and this study aims to figure out which patients are at higher risk for this complication. The trial is open to adults aged 18 and older who have had unscheduled midline laparotomy surgery due to various urgent medical conditions, such as bowel obstruction or inflammatory diseases.
If you or someone you know is eligible and decides to participate, you will help researchers gather important information that could improve patient care in the future. Participants will share their medical history and may have follow-up visits to monitor their recovery. This study is not yet recruiting participants, so there’s no need to take action right now, but it’s a significant step toward enhancing surgical outcomes for patients in emergency situations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of 18 years or above and
- • Unscheduled midline laparotomy in an emergency or subacute setting, involving perforated bowel, bowel obstruction, bowel ischemia (due to mesenteric vascular disease or incarceration), inflammatory diseases (e.g. diverticulitis, appendicitis, ulcerative colitis, cholecystitis and Crohn's disease), abscesses, non-traumatic intraabdominal bleeding and any emergency re-operation to elective surgery
- Exclusion Criteria:
- • Age below 18 years
- • Patients with mental or physical disorders making follow-up impossible
- • Patients were no fascial closure is performed
About Herlev Hospital
Herlev Hospital, a leading healthcare institution located in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a key player in the Danish healthcare system, Herlev Hospital combines cutting-edge facilities with a multidisciplinary approach to research, fostering collaborations among healthcare professionals and researchers. The hospital focuses on a wide range of medical fields, aiming to enhance treatment efficacy and patient care through rigorous scientific inquiry and ethical standards. With a commitment to excellence, Herlev Hospital plays a pivotal role in translating clinical research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials